Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dystrophic Epidermolysis Bullosa”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02579369
What this trial is testing

Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Anterogen Co., Ltd. 2
Testing effectiveness (Phase 2)Ended earlyNCT02810951
What this trial is testing

FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Epidermolysis Bullosa Dystrophica, Recessive
Castle Creek Biosciences, LLC. 6
Very early researchEnded earlyNCT00881556
What this trial is testing

Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Epidermolysis Bullosa
Columbia University 3
Testing effectiveness (Phase 2)Ended earlyNCT03605069
What this trial is testing

A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With Confirmed DDEB or RDEB Diagnosis With One or More Pathogenic Mutations in Exon 73 in the COL7A1 Gene

Who this might be right for
Epidermolysis Bullosa Dystrophica, RecessiveEpidermolysis Bullosa Dystrophica, Dominant
Phoenicis Therapeutics 2
Testing effectiveness (Phase 2)Study completedNCT04520022
What this trial is testing

Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Gangnam Severance Hospital 5
Not applicableStudy completedNCT02178969
What this trial is testing

Short Term Observational Study in DEB Patients

Who this might be right for
Dystrophic Epidermolysis Bullosa
Shire 29
Not applicableUnknownNCT05390073
What this trial is testing

Growth Hormone in EB

Who this might be right for
Epidermolysis Bullosa Dystrophica
Cairo University 50
Early research (Phase 1)Active Not RecruitingNCT06713434
What this trial is testing

Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa

Who this might be right for
Junctional Epidermolysis BullosaEpidermolysis Bullosa (EB)Dystrophic Epidermolysis Bullosa+1 more
Fundación DEBRA Chile, Niños Piel de Cristal 20
Not applicableStudy completedNCT03942250
What this trial is testing

Uses of Irradiated Human Amniotic Membrane in the Treatment of Dystrophic Epidermolysis Bullosa Patients

Who this might be right for
Epidermolysis BullosaChronic Skin Ulcer
Egyptian Atomic Energy Authority 8
Testing effectiveness (Phase 2)UnknownNCT02323789
What this trial is testing

Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
King's College London 10
Large-scale testing (Phase 3)Ended earlyNCT02670330
What this trial is testing

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa
Scioderm, Inc. 152
Not applicableUnknownNCT06177353
What this trial is testing

Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro

Who this might be right for
Epidermolysis Bullosa Dystrophica
Assistance Publique - Hôpitaux de Paris 30
Testing effectiveness (Phase 2)UnknownNCT04153630
What this trial is testing

Safety Study and Preliminary Efficacy of Infusion Haploidentical Mesenchymal Stem Cells Derived From Bone Marrow for Treating Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica, Recessive
Instituto de Investigación Hospital Universitario La Paz 9
Not applicableWithdrawnNCT01768026
What this trial is testing

Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Lotus Tissue Repair, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT02984085
What this trial is testing

Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB.

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Holostem s.r.l. 3
Testing effectiveness (Phase 2)Study completedNCT03012191
What this trial is testing

Gentamicin for RDEB

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
University of Southern California 6
Testing effectiveness (Phase 2)UnknownNCT05157958
What this trial is testing

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Anterogen Co., Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT01538862
What this trial is testing

Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Vanderbilt University Medical Center 7
Testing effectiveness (Phase 2)Looking for participantsNCT06731933
What this trial is testing

Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin

Who this might be right for
Squamous Cell Carcinoma
Stanford University 16
Large-scale testing (Phase 3)Study completedNCT04227106
What this trial is testing

Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa
Abeona Therapeutics, Inc 11
Next Page